Epilepsy and bipolar disorders

References

• Lewis A. Melancholia: a historical review. J. Mental Sci.80, 1–42 (1934).
   Google Scholar
• Temkin O. The Falling Sickness: a History of Epilepsy from the Greeks to the Beginnings of Modern Neurology. John Hopkins University Press, Baltimore, MD USA (1971).
   Google Scholar
• Kanner AM, Balabanov A. Depression and epilepsy: how closely related are they? Neurology58(8 Suppl. 5), S27–S39 (2002).
   PubMed Web of Science ®Google Scholar
• Quiske A, Helmstaedter C, Lux S, Elger CE. Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. Epilepsy Res.39(2), 121–125 (2000).
   PubMed Web of Science ®Google Scholar
• Mula M, Sander JW. Negative effects of antiepileptic drugs on mood in patients with epilepsy. Drug Saf.30(7), 555–567 (2007).
   PubMed Web of Science ®Google Scholar
• Wolf P. Manic episodes in epilepsy. In: Advances in Epileptology: 13th Epilepsy International Symposium. Akimoto H, Kazamatsuri H, Seino M, Ward AA Jr (Eds). Raven Press, New York, USA 237–240 (1982).
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th Edition, Text Revision). American Psychiatric Association, Washington, DC, USA (2000).
   Google Scholar
• Ettinger AB, Reed ML, Goldberg JF, Hirschfeld RM. Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. Neurology65, 535–540 (2005).
   PubMed Web of Science ®Google Scholar
• Mula M, Jauch R, Cavanna A et al. Psychopathological features of the so-called interictal dysphoric disorder of epilepsy. Epilepsia49(6), 650–656 (2008).
   PubMed Web of Science ®Google Scholar
• Mazza M, Della Marca G, Di Nicola M et al. Oxcarbazepine improves mood in patients with epilepsy Epilepsy Behav.10(3), 397–401 (2007).
   PubMed Web of Science ®Google Scholar
• Angst J, A, Benazzi, F, Ajdacic V, Eich D, Rössler W. Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J. Affect. Disord.73, 133–146 (2003).
   PubMed Web of Science ®Google Scholar
• Judd L, Akiskal H S. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J. Affect. Disord.73, 123–131 (2003).
   PubMed Web of Science ®Google Scholar
• Goodwin FK, Jamison K. Manic-Depressive Illness, 2nd Edition. Oxford University Press, NY, USA (2007).
   Google Scholar
• Sadler MJ. Falret’s discovery: the origin of the concept of bipolar affective illness. Sedler MJ, Dessain EC (Translators). Am. J. Psychiatry140(9), 1127–1133 (1983).
   PubMed Web of Science ®Google Scholar
• Cassano GB, Mula M, Rucci P et al. The structure of lifetime manic-hypomanic spectrum. J. Affect. Disord.112(1–3), 59–70 (2009).
   PubMed Web of Science ®Google Scholar
• Kwan P, Sander JW. The natural history of epilepsy: an epidemiological view. J. Neurol. Neurosurg. Psychiatry75(10), 1376–1381 (2004).
   PubMed Web of Science ®Google Scholar
• Maj M, Pirozzi R, Magliano L, Bartoli L. Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. Am. J. Psychiatry155(1), 30–35 (1998).
   PubMed Web of Science ®Google Scholar
• Angst J, Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol. Psychiatry48(6), 445–457 (2000).
   PubMed Web of Science ®Google Scholar
• Amann B, Grunze H. Neurochemical underpinnings in bipolar disorder and epilepsy. Epilepsia46(Suppl. 4), 26–30 (2005).
   PubMed Web of Science ®Google Scholar
• Mazza M, Di Nicola M, Della Marca G, Janiri L, Bria P, Mazza S. Bipolar disorder and epilepsy: a bidirectional relation? Neurobiological underpinnings, current hypotheses, and future research directions. Neuroscientist13(4), 392–404 (2007).
   PubMed Web of Science ®Google Scholar
• Goddard GV, McIntyre DC, Leech CK. A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol.25(3), 295–330 (1969).
   PubMed Web of Science ®Google Scholar
• Post RM. Neurobiology of seizures and behavioral abnormalities. Epilepsia45(Suppl. 2), 5–14 (2004).
   PubMedGoogle Scholar
• Post RM, Uhde TW, Putnam FW, Ballenger JC, Berrettini WH. Kindling and carbamazepine in affective illness. J. Nerv. Ment. Dis.170(12), 717–731 (1982).
   PubMed Web of Science ®Google Scholar
• Morimoto K, Sato H, Yamamoto Y, Watanabe T, Suwaki H. Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy. Epilepsia38(9), 966–974 (1997).
   PubMed Web of Science ®Google Scholar
• Post RM, Weiss SR. A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures. Mol. Neurobiol.13(1), 33–60 (1996).
   PubMed Web of Science ®Google Scholar
• Kupka R, Post R. Kindling as a model for affective disorders. In: Seizures, Affective Disorders and Anticonvulsant Drugs. Trimble M, Schmitz B (Eds). Clarius Press, Guilford, UK (2002).
   Google Scholar
• Maes M, Verkerk R, Vandoolaeghe E et al. Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response. Eur. Arch. Psychiatry Clin. Neurosci.247(3), 154–161 (1997).
   PubMedGoogle Scholar
• Clinckers R, Smolders I, Meurs A, Ebinger G, Michotte Y. Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors. J. Neurochem.89(4), 834–843 (2004).
   PubMed Web of Science ®Google Scholar
• Petty F. Plasma concentrations of γ-aminobutyric acid (GABA) and mood disorders: a blood test for manic depressive disease? Clin. Chem.40(2), 296–302 (1994).
   PubMed Web of Science ®Google Scholar
• Guidotti A, Auta J, Davis JM et al. Decrease in reelin and glutamic acid decarboxylase 67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry57(11), 1061–1069 (2000).
   PubMed Web of Science ®Google Scholar
• Post RM, Speer AM, Hough CJ, Xing G. Neurobiology of bipolar illness: implications for future study and therapeutics. Ann. Clin. Psychiatry15(2), 85–94 (2003).
   PubMedGoogle Scholar
• Speckmann EJ, Straub H, Köhling R. Contribution of calcium ions to the generation of epileptic activity and antiepileptic calcium antagonism. Neuropsychobiology27(3), 122–126 (1993).
   PubMedGoogle Scholar
• Dubovsky SL, Thomas M, Hijazi A, Murphy J. Intracellular calcium signaling in peripheral cells of patients with bipolar affective disorder. Eur. Arch. Psychiatry Clin. Neurosci.243(5), 229–234 (1994).
   PubMed Web of Science ®Google Scholar
• Kraepelin E. Psychiatrie. Band 3. Johann Ambrosius Barth, Leipzig, Germany, (1923).
   Google Scholar
• Bleuler E. Lehrbuch der Psychiatrie. 8th Edition. Springer-Verlag, Berlin, Germany, (1949).
   Google Scholar
• Gastaut H, Morin G, Lesevre N. Etude du comportement des epileptiques psychomoteurs dans l’intervalle de leurs crises: les troubles de l’activitè globale et de la sociabilitè. Ann. Med. Psychol. (Paris)113, 1–27 (1955).
   PubMed Web of Science ®Google Scholar
• Blumer D. Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders. Harv. Rev. Psychiatry8(1), 8–17 (2000).
   PubMed Web of Science ®Google Scholar
• Himmelhoch JM. Major mood disorders related to epileptic changes. In: Psychiatric aspects of epilepsy. Blumer D (Ed). American Psychiatric Press, Washington DC, USA, 271–294 (1984)
   Google Scholar
• Kanner AM. Psychiatric comorbidity in patients with developmental disorders and epilepsy: a practical approach to its diagnosis and treatment. Epilepsy Behav.3(6 Suppl. 1), 7–13 (2002).
   PubMed Web of Science ®Google Scholar
• Möller HJ Curtis VA The bipolar spectrum: diagnostic and pharmacologic considerations. Expert Rev. Neurother.4(6 Suppl. 2), S3–S8 (2004).
   PubMedGoogle Scholar
• Benazzi F. Is there a continuity between bipolar and depressive disorders? Psychother. Psychosom.76(2), 70–76 (2007).
   PubMedGoogle Scholar
• Hirschfeld RM, Holzer C, Calabrese JR et al. Validity of the mood disorder questionnaire: a general population study. Am. J. Psychiatry160(1), 178–180. (2003).
   PubMed Web of Science ®Google Scholar
• Akiskal HS, Pinto O The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr. Clin. North Am.22(3), 517–534, (1999).
   PubMed Web of Science ®Google Scholar
• Blumer D, Montouris G, Davies K. The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy. Epilepsy Behav.5, 826–840 (2004).
   PubMed Web of Science ®Google Scholar
• Mula M, Schmitz B, Jauch R et al. On the prevalence of bipolar disorder in epilepsy. Epilepsy Behav.13(4), 658–661 (2008).
   PubMed Web of Science ®Google Scholar
• Akiskal HS. Temperament and mood disorders. Harv. Ment. Health Lett.16(8), 5–6 (2000).
   PubMedGoogle Scholar
• Kanner AM. Peri-ictal psychiatric phenomena: clinical characteristics and implications of past and future psychiatric disorders. In: Psychiatric Issues in Epilepsy: a Practical Guide to Diagnosis and Treatment (2nd Edition). Ettinger A, Kanner AM (Eds). Lippincott, Wiliams & Wilkins, Philadelphia, PA, USA, 321–345 (2007).
   Google Scholar
• Kanner. Do peri-ictal psychiatric symptoms account for the differences between depressive disorders in patients with and without epilepsy? In: Psychiatric controversies in epilepsy. Kanner AM, Schachter S (Eds). Elsevier, New York, NY, USA, 201–209 (2008).
   Google Scholar
• Blanchet P, Frommer GP. Mood change preceding epileptic seizures. J. Nerv. Ment. Dis.174(8), 471–476 (1986).
   PubMed Web of Science ®Google Scholar
• Scaramelli A, Braga P, Avellanal A et al. Prodromal symptoms in epileptic patients: clinical characterization of the pre-ictal phase. Seizure18(4), 246–250 (2009).
   PubMed Web of Science ®Google Scholar
• Fisher RS, Schachter SC. The postictal state: a neglected entity in the management of epilepsy. Epilepsy Behav.1(1), 52–59 (2000).
   PubMed Web of Science ®Google Scholar
• Boylan LS. Peri-ictal behavioral and cognitive changes. Epilepsy Behav.3(1), 16–26 (2002).
   PubMed Web of Science ®Google Scholar
• Kanner AM, Soto A, Gross-Kanner H. Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology62, 708–713 (2004).
   PubMed Web of Science ®Google Scholar
• Nishida T, Kudo T, Inoue Y et al. Postictal mania versus postictal psychosis: differences in clinical features, epileptogenic zone, and brain functional changes during postictal period. Epilepsia47(12), 2104–2114 (2006).
   PubMed Web of Science ®Google Scholar
• Kanemoto K. Postictal psychoses, revisited. In: The Neuropsychiatry of Epilepsy. Trimble M, Schmitz B (Eds). Cambridge University Press, Cambridge, UK, 117–131 (2002).
   Google Scholar
• Landolt H. Serial electroencephalographic investigations during psychotic episodes in epileptic patients and during schizophrenic attacks. In: Lectures on Epilepsy. Lorentz de Haas AM (Ed.). Elsevier, Amsterdam, The Netherlands, 91–133 (1958).
   Google Scholar
• Wolf P. The clinical syndromes of forced normalization. Folia Psychiatr. Neurol. Jpn38, 187–192 (1984).
   Google Scholar
• Monaco F, Mula M. Phenytoin and other hydantoins. Clinical efficacy and use in psychiatric disorders. In: Antiepileptic Drugs (5th Edition). Levy RH, Mattson RH, Meldrum BS, Perucca E (Eds). Lippincott, Wiliams & Wilkins, Philadelphia, PA, USA, 600–604 (2002).
   Google Scholar
• Ettinger AB. Psychotropic effects of antiepileptic drugs. Neurology67(11), 1916–1925 (2006).
   PubMed Web of Science ®Google Scholar
• Ceron-Litvoc D, Soares BG, Geddes J, Litvoc J, de Lima MS. Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials. Hum. Psychopharmacol.24(1), 19–28 (2009).
   PubMed Web of Science ®Google Scholar
• Spina E, Perugi G. Antiepileptic drugs: indications other than epilepsy. Epileptic Disord.6, 57–75 (2004).
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Practice Guideline for the Treatment of Patients with Bipolar Disorder (Revision). Am. J. Psychiatry159(Suppl. 4), 1–50 (2002).
   Web of Science ®Google Scholar
• Goodwin GM. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J. Psychopharmacol.17(2), 149–173 (2003).
   PubMed Web of Science ®Google Scholar
• Haddad PM, Das A, Ashfaq M, Wieck A. A review of valproate in psychiatric practice. Expert Opin. Drug Metab. Toxicol.5(5), 539–551 (2009).
   PubMed Web of Science ®Google Scholar
• Mula M, Cavanna AE, Monaco F. Psychopharmacology of topiramate: from epilepsy to bipolar disorder. Neuropsychiatr. Dis. Treat.2(4), 475–488 (2006).
   PubMedGoogle Scholar
• Mula M, Pini S, Cassano GB. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence. J. Clin. Psychopharmacol.27(3), 263–272 (2007).
   PubMed Web of Science ®Google Scholar
• Krauthammer C, Klerman GL. Secondary mania: manic syndrome associated with antecedent physical illness or drugs. Arch. Gen. Psychiatry30, 74–79 (1978).
   Google Scholar
• Mula M, Monaco F. Antiepileptic drug-induced mania in patients with epilepsy: what do we know? Epilepsy Behav.9(2), 265–267. (2006).
   PubMed Web of Science ®Google Scholar
• Kugoh T, Watanabe M, Obayashi K, Fujioka K, Hosokawa K. Two cases with epilepsy who manifested manic-depressive symptoms under barbiturates treatment. J. Psychiatry Neurol.45(2), 437–438 (1991).
   Google Scholar
• Patten SB, Klein GM, Lussier C, Sawa R. Organic mania induced by phenytoin: a case report. Can. J. Psychiatry34(8), 827–828 (1989).
   PubMed Web of Science ®Google Scholar
• Reiss Al, O’Donnell DJ. Carbamazepine-induced mania in two children: case report. J. Clin. Psychiatry45(6), 272–274 (1984).
   PubMed Web of Science ®Google Scholar
• Drake ME Jr, Peruzzi WT. Manic state with carbamazepine therapy of seizure. J. Nat. Med. Assoc.78(11), 1105–1107 (1986).
   PubMed Web of Science ®Google Scholar
• Scull DA, Trimble MR. Mania precipitated by carbamazepine withdrawal. Br. J. Psychiatry167(5), 698 (1995).
   PubMed Web of Science ®Google Scholar
• Sastre-Garau P, Thomas P, Beaussart M, Goudemand M. Subsequent manic onset caused by association of vigabatrin-clomipramine. Encephale4, 51–52 (1993).
   Google Scholar
• Short C, Cooke L. Hypomania induced by gabapentin. Br. J. Psychiatry166(5), 679–680 (1995).
   PubMed Web of Science ®Google Scholar
• Hill RR, Stagno SJ, Tesar GE. Secondary mania associated with the use of felbamate. Psychosomatics36(4), 404–406 (1995).
   PubMed Web of Science ®Google Scholar
• Schlatter FJ, Soutullo CA, Cervera-Enguix S. First break mania associated with topiramate treatment. J. Clin. Psychopharmacol.21(4), 464–466 (2001).
   PubMed Web of Science ®Google Scholar
• Jochum T, Bar KJ, Sauer H. Topiramate induced manic episode. J. Neurol. Neurosurg. Psychiatry73(2), 208–209 (2002).
   PubMed Web of Science ®Google Scholar
• Charles CL, Stoesz L, Tollefson G. Zonisamide-induced mania. Psychosomatics31(2), 214–217 (1990).
   PubMed Web of Science ®Google Scholar
• Ozawa K, Kobayashi K, Noda S, Iyo M. Zonisamide-induced depression and mania in patients with epilepsy. J. Clin. Psychopharmacol.24(1), 110–111 (2004).
   PubMed Web of Science ®Google Scholar
• Klein JP, Jean-Baptiste M, Thompson JL, Bowers MB Jr. A case of hypomania following vagus nerve stimulation for refractory epilepsy. J. Clin. Psychiatry64(4), 485 (2003).
   PubMed Web of Science ®Google Scholar
• Barry JJ, Ettinger AB, Friel P et al. Advisory Group of the Epilepsy Foundation as part of its Mood Disorder. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav.13(Suppl. 1), S1–29 (2008).
   Web of Science ®Google Scholar
• Bauer M, Beaulieu S, Dunner DL, Lafer B, Kupka R. Rapid cycling bipolar disorder – diagnostic concepts. Bipolar Disord.10(1 Pt 2), 153–162 (2008).
   PubMed Web of Science ®Google Scholar
• Grunze H, Kasper S, Goodwin G et al. World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Bipolar Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: treatment of bipolar depression. World J. Biol. Psychiatry3(3), 115–124 (2002).
   PubMedGoogle Scholar
• Trimble MR, Krishnamoorthy ES. The use of ECT in neuropsychiatric disorders. In: The ECT handbook (2nd Edition). Scott AIF (Ed.). The Royal College of Psychiatrists, London, UK, 47–56 (2005).
   Google Scholar
• Fountoulakis KN, Vieta E. Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. Int. J. Neuropsychopharmacol.11(7), 999–1029 (2008).
   PubMedGoogle Scholar
• Azorin JM, Kaladjian A. An update on the treatment of bipolar depression. Expert Opin. Pharmacother.10(2), 161–172 (2009).
   PubMed Web of Science ®Google Scholar
• Gao K, Kemp DE, Ganocy SJ, Gajwani P, Xia G, Calabrese JR. Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review. J. Clin. Psychopharmacol.28(2), 203–209 (2008).
   PubMed Web of Science ®Google Scholar
• Kramlinger KG, Post RM. Addition of lithium carbonate to carbamazepine: haematological and thyroid effects. Am. J. Psychiatry147, 615–620 (1990).
   PubMed Web of Science ®Google Scholar
• Vieweg V, Shutty M, Hundley P, Leadbetter R. Combined treatment with lithium and carbamazepine. Am. J. Psychiatry148, 398–399 (1991).
   PubMed Web of Science ®Google Scholar
• Hensiek A, Trimble MR. Relevance of new psychotropic drugs for the neurologist. J. Neurol. Neurosurg. Psychiatry72, 281–285 (2002).
   PubMed Web of Science ®Google Scholar
• Freeman MP, Stool AL. Mood stabilizer combinations: a review of safety and efficacy. Am. J. Psychiatry155, 12–21 (1998).
   PubMed Web of Science ®Google Scholar
• Chen C, Veronese L, Yin Y. The effects of lamotrigine on the pharmacokinetics of lithium. Br. J. Clin. Pharmacol.50, 193–195 (2000).
   PubMed Web of Science ®Google Scholar
• Abraham G, Owen J. Topiramate can cause lithium toxicity. J. Clin. Psychopharmacol.24, 565–567 (2004).
   PubMed Web of Science ®Google Scholar
• Erwin CV, Gerber CJ, Morrison SD, James JF. Lithium carbonate and convulsive disorders. Arch. Gen. Psychiatry28, 646–648 (1973).
   PubMed Web of Science ®Google Scholar
• Jus A, Villenueve A, Gautier J et al. Influence of lithium carbonate on patients with temporal epilepsy. Can. Psychiatr. Assoc. J.18, 77–78 (1973).
   PubMedGoogle Scholar
• Grunze H, Kasper S, Goodwin G, Bowden C, Möller HJ. WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J. Biol. Psychiatry5(3), 120–135 (2004).
   PubMed Web of Science ®Google Scholar
• Suppes T, Dennehy EB, Hirschfeld RM et al. Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J. Clin. Psychiatry66(7), 870–886 (2005).
   PubMed Web of Science ®Google Scholar
• Koch-Stoecker S. Antipsychotic drugs and epilepsy: indications and treatment guidelines. Epilepsia43(Suppl. 2), 19–24 (2002).
   PubMed Web of Science ®Google Scholar
• Schmitz B. Antidepressant drugs: indications and guidelines for use in epilepsy. Epilepsia43(Suppl. 2), 13–18 (2002).
   Google Scholar
• Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol. Psychiatry62, 345–354 (2007).
   PubMed Web of Science ®Google Scholar
• Dailey JW, Naritoku DK. Antidepressants and seizures: clinical anecdotes overshadow neuroscience. Biochem. Pharmacol.52, 1323–1329 (1996).
   PubMed Web of Science ®Google Scholar
• Jobe PC, Browning RS. The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. Epilepsy Behav.7, 602–619 (2005).
   PubMed Web of Science ®Google Scholar